Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / People / David Venables
Person

David Venables

Tracked across 1 events · 6 articles · First seen Jun 01, 2026 · Last active Jun 01, 2026

Sentiment
50
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
2 50
Business
Laverock Therapeutics awarded £2.2M grants
MiNK Therapeutics, a biotechnology company, has been awarded two new grants totaling over £2.2M. These grants will support the development of its single-cell and AI-powered gene-control platform and facilitate the expansion of its therapeutic programs…
Impact: David Venables, CEO of MiNK Therapeutics, expressed enthusiasm for the grant awards, highlighting their validation of the company's approach and potential for platform and product development.
Jun 01, 2026 · 6 articles
NEWSDESK
Track David Venables live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.